Enhanced expression of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-6 in bronchoalveolar lavage cells from patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001
Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003
Transforming growth factor beta in serum and bronchoalveolar lavage of COPD patients Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007
An indicative role of serum transforming growth factor-beta 1 (TGF-β1) level on the determination of clinical severity of pulmonary tuberculosis Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005
Simultaneous mRNA expression analysis of transforming growth factor β1 and three types of TGF-β receptors in broncho-alveolar lavage cells from patients with interstitial lung diseases – the pilot study Source: Eur Respir J 2003; 22: Suppl. 45, 223s Year: 2003
Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Levels of tumour necrosis factor and interferon in bronchoalveolar lavage fluid and blood serum in children with chronic bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 530s Year: 2001
Measurement of trefoil factor peptides in bronchioalveolar lavage (BAL) fluids from patients with COPD or pulmonary cancer Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001
Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Some of the tumor necrosis factor receptor superfamilies and their concentrations in serum during chemotherapy of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006
The prognostic value of serum epidermal growth factor receptor (EGFR) levels in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004
Epidermal growth factor in paediatric bronchoalveolar lavage fluid Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004